Literature DB >> 8688750

Vaccines, malaria, and a host of resistance.

M Dobson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8688750      PMCID： PMC2351521          DOI： 10.1136/bmj.313.7049.67

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  The legacy of Edward Jenner.

Authors:  M M Levine
Journal:  BMJ       Date:  1996-05-11

2.  History of malaria in England.

Authors:  M J Dobson
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

3.  Malaria. That vaccine passes a trial.

Authors:  F E Cox
Journal:  Nature       Date:  1993-04-01       Impact factor: 49.962

Review 4.  Malaria vaccines.

Authors:  A Moreno; M E Patarroyo
Journal:  Curr Opin Immunol       Date:  1995-10       Impact factor: 7.486

Review 5.  Malaria vaccine trials: SPf66 and all that.

Authors:  E Riley
Journal:  Curr Opin Immunol       Date:  1995-10       Impact factor: 7.486

6.  Malaria vaccine raises a dilemma.

Authors:  J Maurice
Journal:  Science       Date:  1995-01-20       Impact factor: 47.728

7.  Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

Authors:  P L Alonso; T Smith; J R Schellenberg; H Masanja; S Mwankusye; H Urassa; I Bastos de Azevedo; J Chongela; S Kobero; C Menendez
Journal:  Lancet       Date:  1994-10-29       Impact factor: 79.321

8.  A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

Authors:  M E Patarroyo; R Amador; P Clavijo; A Moreno; F Guzman; P Romero; R Tascon; A Franco; L A Murillo; G Ponton
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

9.  Efficacy trial of malaria vaccine SPf66 in Gambian infants.

Authors:  U D'Alessandro; A Leach; C J Drakeley; S Bennett; B O Olaleye; G W Fegan; M Jawara; P Langerock; M O George; G A Targett
Journal:  Lancet       Date:  1995-08-19       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.